Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Washington
University College, London
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Ossium Health, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Medical College of Wisconsin
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
City of Hope Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Sanofi
Institut Bergonié
Seagen Inc.
Universität des Saarlandes
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
European Organisation for Research and Treatment of Cancer - EORTC
University of Miami
M.D. Anderson Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
City of Hope Medical Center
St. Jude Children's Research Hospital
University College, London
Children's Oncology Group
University of Nebraska
Washington University School of Medicine
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute